Clinical Trials at Mission Hospital
As of August 2026, 26 paid clinical trials are recruiting at Mission Hospital, located at 400 RIDGEFIELD CT STE 203.04, ASHEVILLE, NC 28806-2213, phone (828) 257-7204 in Asheville, North Carolina. Active studies at this site cover conditions such as Heart Failure, Malignant Solid Neoplasm and Acute Myeloid Leukemia. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
26 clinical trials at Mission Hospital
·Clear filters·Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
Virtue® SAB in the Treatment of Coronary ISR Trial
Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Project: Every Child for Younger Patients With Cancer
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Alleviant ALLAY-HFrEF Study
Alleviant ALLAY-HF Study
Common conditions studied in Asheville
- Heart Failure (5 active studies)
- Malignant Solid Neoplasm (4 active studies)
- Acute Myeloid Leukemia (3 active studies)
- Graves' Disease (3 active studies)
- Acute Lymphoblastic Leukemia (2 active studies)
- Age-Related Macular Degeneration (2 active studies)
Leading research sponsors in Asheville
- Children's Oncology Group
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- VA Office of Research and Development
- Alleviant Medical, Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in Asheville?
There are approximately 87 recruiting clinical trials in Asheville, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Asheville pay participants?
Most recruiting trials in Asheville compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Asheville?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Asheville?
The most common conditions under active study in Asheville include Heart Failure (5), Malignant Solid Neoplasm (4), Acute Myeloid Leukemia (3), Graves' Disease (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Asheville?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Asheville on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Asheville?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Asheville?
Recruiting research sites in Asheville include Mission Hospital, AdventHealth Infusion Center Asheville, Messino Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Asheville right now?
The largest active categories in Asheville are Cancer & tumors (23), Cardiovascular (15), Eye & vision (7). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Mission Hospital?
Mission Hospital is located at 400 RIDGEFIELD CT STE 203.04, ASHEVILLE, NC 28806-2213. Use the Google Maps link in the intro above to get directions.
How do I contact Mission Hospital?
You can reach Mission Hospital by phone at (828) 257-7204. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.